Bad memory? Poor sleep habits? These inherited traits may come from your parents. But who's to blame? Here's what the science ...

ABSTRACT: Background: Renal manifestations, including glomerular hyperfiltration during sickle cell disease (SCD), are very frequent and constitute the starting point for renal failure. Few data are ...

One of the reasons of anemia can be Sickle Cell Anemia (SCA)—a genetic blood disorder where the body produces red blood cells that are abnormally shaped.” Also read | Sickle cell disease ...

Higher economic deprivation also associated with brain age gap in controls without sickle cell anemia. (HealthDay News) — Adults with sickle cell anemia (SCA) and healthy controls with greater ...

The presence of abnormal hemoglobin (HbS, HbC, or HbE) may indicate sickle cell disease or anemia. 5 In addition to hemoglobin electrophoresis ... and within 2 to 4 weeks if the results are abnormal.

Mehmet Tunc Onur Sanli Mehmet Tunc Onur Sanli was diagnosed with sickle cell disease when he was 11. The 42-year-old, from London, said: “Because of my illness, I often experience pain in my chest, ...

Overall, our study underscores the dynamic and cyclical nature of chromosome stiffness, modulated by both the cell cycle and age-related factors. Chromosome compaction is not a random process, but a ...

Though GNN has reported that several sickle cell disease patients have already been successfully treated with CRISPR gene editing technology, a new method of addressing this debilitating condition ...

The role of genetics Sickle cell disease occurs when a person inherits two copies of the sickle cell gene, one from each parent. If both parents are carriers, there is a 25 percent chance of ...

Also, as they age, some men can lose their Y chromosomes in blood due to errors in cell division. This loss is associated with conditions like Alzheimer's disease or cancer, so the lab is now ...

Novo Nordisk is opening a new front in its fight against sickle cell disease, inking a deal with IMMvention Therapeutix to co-develop oral treatments for the red blood cell disorder and other ...